Barclays’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-21
| Closed | -$4K | – | 5525 |
|
|
2020
Q2 | $4K | Sell |
21
-249
| -92% | -$58.8K | ﹤0.01% | 5407 |
|
|
2020
Q1 | $61K | Buy |
+270
| New | +$77K | ﹤0.01% | 5106 |
|
|
2019
Q4 | – | Sell |
-32
| Closed | -$10K | – | 6737 |
|
|
2019
Q3 | $10K | Sell |
32
-283
| -90% | -$87K | ﹤0.01% | 6348 |
|
|
2019
Q2 | $104K | Buy |
315
+9
| +3% | +$4.57K | ﹤0.01% | 5664 |
|
|
2019
Q1 | $192K | Buy |
306
+154
| +101% | +$70.3K | ﹤0.01% | 4860 |
|
|
2018
Q4 | $38K | Buy |
152
+91
| +149% | +$36.2K | ﹤0.01% | 5618 |
|
|
2018
Q3 | $28K | Sell |
61
-288
| -83% | -$139K | ﹤0.01% | 6344 |
|
|
2018
Q2 | $189K | Buy |
349
+320
| +1,103% | +$192K | ﹤0.01% | 4774 |
|
|
2018
Q1 | $17K | Sell |
29
-130
| -82% | -$82.1K | ﹤0.01% | 6492 |
|
|
2017
Q4 | $102K | Sell |
159
-84
| -35% | -$59.2K | ﹤0.01% | 5228 |
|
|
2017
Q3 | $229K | Buy |
243
+223
| +1,115% | +$171K | ﹤0.01% | 4311 |
|
|
2017
Q2 | $17K | Buy |
20
+16
| +400% | +$13.1K | ﹤0.01% | 5877 |
|
|
2017
Q1 | $3K | Sell |
4
-23
| -85% | -$15.2K | ﹤0.01% | 6402 |
|
|
2016
Q4 | $20K | Buy |
27
+26
| +2,600% | +$18K | ﹤0.01% | 5620 |
|
|
2016
Q3 | $1K | Sell |
1
-136
| -99% | -$110K | ﹤0.01% | 6430 |
|
|
2016
Q2 | $114K | Sell |
137
-23
| -14% | -$21.4K | ﹤0.01% | 4316 |
|
|
2016
Q1 | $123K | Sell |
160
-321
| -67% | -$252K | ﹤0.01% | 4209 |
|
|
2015
Q4 | $529K | Buy |
481
+27
| +6% | +$31.4K | ﹤0.01% | 3170 |
|
|
2015
Q3 | $349K | Sell |
454
-159
| -26% | -$230K | ﹤0.01% | 3675 |
|
|
2015
Q2 | $1.08M | Sell |
613
-327
| -35% | -$416K | ﹤0.01% | 2819 |
|
|
2015
Q1 | $1.03M | Sell |
940
-589
| -39% | -$690K | ﹤0.01% | 2952 |
|
|
2014
Q4 | $1.68M | Buy |
1,529
+78
| +5% | +$80K | ﹤0.01% | 2682 |
|
|
2014
Q3 | $1.44M | Sell |
1,451
-197
| -12% | -$223K | ﹤0.01% | 2974 |
|
|
2014
Q2 | $1.99M | Sell |
1,648
-562
| -25% | -$676K | ﹤0.01% | 2601 |
|
|
2014
Q1 | $2.92M | Buy |
2,210
+1,246
| +129% | +$1.62M | ﹤0.01% | 2191 |
|
|
2013
Q4 | $1.06M | Buy |
964
+412
| +75% | +$568K | ﹤0.01% | 3333 |
|
|
2013
Q3 | $668K | Buy |
552
+442
| +402% | +$300K | ﹤0.01% | 3789 |
|
|
2013
Q2 | $44K | Buy |
+110
| New | +$46.6K | ﹤0.01% | 6387 |
|
Other funds holding RMTI
AC
GC
Barclays's RMTI Position: Q2 2025 in Review
Barclays sold out of Rockwell Medical (RMTI) in Q2 2025, closing a stake of 125 shares — an estimated $1.42K sold.
Barclays first reported a position in RMTI in Q2 2013 and held it in 37 quarters. The position peaked at $1.08M in Q3 2013. 41 funds tracked by Wall St. Rank hold RMTI as of Q2 2025.
- Barclays reported no remaining Rockwell Medical position as of Q2 2025 after selling out during the quarter.
- Barclays sold 125 Rockwell Medical shares in Q2 2025, an estimated $1.42K.
- Barclays first reported a position in Rockwell Medical in Q2 2013 and held it in 37 quarters.
- Barclays's Rockwell Medical position peaked at $1.08M in Q3 2013.
- 41 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2025.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.